We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
ACCEPT Reject
Already have an account? Sign in.

 Remember Me | Forgot Your Password?
Home Manage Alerts Archive Archive About Us Register Now   Not a User? Join now

Rimonabant Trial “Inconclusive”

April 9, 2008: 12:00 AM EST
A trial of Rimonabant as a weight-loss drug in the US has proved inconclusive. The Sanofi-Aventis drug is available in Europe, but has not been approved in the US because of its high rate of adverse psychiatric side effects, including anxiety and depression. The clinic-led study of 839 patients found some evidence the therapy did reduce progression of coronary blockages in high-risk patients, but doctors said the results were not convincing.
"Study Shows Weight Loss may not Cut Coronary Risk", Newhouse News Service, April 09, 2008, © New OrleansNet
Domains
HEALTH & WELLNESS
Body
Food & Nutrition
Dieting & Weight Control
Heart & Cardiovascular
Pills & Supplements
Geographies
Worldwide
North America
United States of America
Categories
Research, Studies, Advice
Home | Privacy Policy | Terms and Conditions | Contact Us Copyright © 2000-2024 Business360 Inc. All Rights Reserved
Developed by Yuri Ingultsov Software Lab.